Drugs / Salirumab
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03784261 Comparator | Dec 2018 → Dec 2022 | rheumatoid arthritis | Shinshu University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salirumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03784261 ↗ |
| Route | Subcutaneous | “SAR, usually subucutaneous injection every 2 weeks” NCT03784261 ↗ |